Teladoc Health Inc.

8.12
-0.44 (-5.14%)
At close: Mar 28, 2025, 3:59 PM
8.06
-0.68%
After-hours: Mar 28, 2025, 06:52 PM EDT

Teladoc Health Statistics

Share Statistics

Teladoc Health has 173.67M shares outstanding. The number of shares has increased by 3.07% in one year.

Shares Outstanding 173.67M
Shares Change (YoY) 3.07%
Shares Change (QoQ) 0.55%
Owned by Institutions (%) 75.02%
Shares Floating 171.88M
Failed to Deliver (FTD) Shares 6.26K
FTD / Avg. Volume 0.08%

Short Selling Information

The latest short interest is 23.5M, so 13.65% of the outstanding shares have been sold short.

Short Interest 23.5M
Short % of Shares Out 13.65%
Short % of Float 13.94%
Short Ratio (days to cover) 5.57

Valuation Ratios

The PE ratio is -1.55 and the forward PE ratio is -10.04. Teladoc Health's PEG ratio is 0.

PE Ratio -1.55
Forward PE -10.04
PS Ratio 0.6
Forward PS 0.5
PB Ratio 1.04
P/FCF Ratio 5.48
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Teladoc Health Inc. has an Enterprise Value (EV) of 4.02B.

EV / Earnings -4.01
EV / Sales 1.56
EV / EBITDA -6.84
EV / EBIT -3.93
EV / FCF 14.19

Financial Position

The company has a current ratio of 1.77, with a Debt / Equity ratio of 1.06.

Current Ratio 1.77
Quick Ratio 1.73
Debt / Equity 1.06
Total Debt / Capitalization 51.52
Cash Flow / Debt 0.19
Interest Coverage -42.89

Financial Efficiency

Return on equity (ROE) is -0.67% and return on capital (ROIC) is -33.45%.

Return on Equity (ROE) -0.67%
Return on Assets (ROA) -0.28%
Return on Capital (ROIC) -33.45%
Revenue Per Employee $556,184.85
Profits Per Employee $-216,719.7
Employee Count 4,620
Asset Turnover 0.73
Inventory Turnover 19.7

Taxes

Income Tax 7.59M
Effective Tax Rate -0.01

Stock Price Statistics

The stock price has increased by -43.38% in the last 52 weeks. The beta is 1.27, so Teladoc Health's price volatility has been higher than the market average.

Beta 1.27
52-Week Price Change -43.38%
50-Day Moving Average 10.27
200-Day Moving Average 9.4
Relative Strength Index (RSI) 39.95
Average Volume (20 Days) 7.65M

Income Statement

In the last 12 months, Teladoc Health had revenue of 2.57B and earned -1B in profits. Earnings per share was -5.87.

Revenue 2.57B
Gross Profit 1.82B
Operating Income -1.02B
Net Income -1B
EBITDA -587.01M
EBIT -1.02B
Earnings Per Share (EPS) -5.87
Full Income Statement

Balance Sheet

The company has 1.3B in cash and 1.58B in debt, giving a net cash position of -286.29M.

Cash & Cash Equivalents 1.3B
Total Debt 1.58B
Net Cash -286.29M
Retained Earnings -16.23B
Total Assets 3.52B
Working Capital 722.37M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 293.68M and capital expenditures -10.79M, giving a free cash flow of 282.89M.

Operating Cash Flow 293.68M
Capital Expenditures -10.79M
Free Cash Flow 282.89M
FCF Per Share 1.66
Full Cash Flow Statement

Margins

Gross margin is 70.76%, with operating and profit margins of -39.73% and -38.97%.

Gross Margin 70.76%
Operating Margin -39.73%
Pretax Margin -38.67%
Profit Margin -38.97%
EBITDA Margin -22.84%
EBIT Margin -39.73%
FCF Margin 11.01%

Dividends & Yields

TDOC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -68.65%
FCF Yield 19.05%
Dividend Details

Analyst Forecast

The average price target for TDOC is $11, which is 28.7% higher than the current price. The consensus rating is "Hold".

Price Target $11
Price Target Difference 28.7%
Analyst Consensus Hold
Analyst Count 18
Stock Forecasts

Scores

Altman Z-Score -5.95
Piotroski F-Score 3